NovaBay Pharmaceuticals Rebrands to Stablecoin Development Corp After $134M Pivot

NovaBay Pharmaceuticals has officially rebranded as Stablecoin Development Corporation, marking a total strategic shift in its business model. This transformation follows a substantial investment of $134 million aimed at pivoting the company toward the cryptocurrency market. The rebranding signifies a specific shift toward integrating stablecoins into the healthcare sector, targeting the reshaping of payment systems and industry dynamics. As part of this new direction, the company now holds approximately 9% of the total supply of the SKY token, positioning it as a significant stakeholder within the Sky ecosystem, formerly known as MakerDAO. Analysts view this as a notable endorsement of the Sky protocol, although the company's nanocap status may limit its broader market influence. This move reflects a growing trend of traditional firms seeking treasury management and infrastructure opportunities within the decentralized finance (DeFi) space.

来源:coindesk.comstocktitan.netcryptobriefing.comainvest.comquiverquant.comtodayonchain.com